Insights

Innovative Product Launches Revance has recently launched new aesthetic and skincare products such as the Teoxane RHA Collection and the PanOxyl Acne Gel Wash, indicating ongoing product development that could benefit from advanced sales enablement tools and customer engagement platforms.

Expansion in Aesthetic Market With its focus on aesthetics and skincare, Revance is positioned in a high-growth segment that is increasingly driven by technological innovation, offering opportunities for partnerships in marketing automation, CRM integration, and data analytics to boost customer reach.

Strategic Leadership Appointments Recent high-level hires including a new CEO and CFO suggest a strategic focus on scaled growth and market expansion, creating potential for upselling enterprise-grade technologies and compliance solutions to support corporate governance.

Financial Growth Potential Revance reports substantial revenue between 250M and 500M dollars with recent funding of 100M, indicating financial stability and growth prospects that could be leveraged for offering scalable SaaS solutions, enterprise software, and consulting services.

Market Position & Competitors As a key player among competitors like Merz Aesthetics and Galderma, Revance's market position presents opportunities for tailored marketing, competitive intelligence tools, and customer relationship management solutions to enhance their market share and customer loyalty.

Similar companies to Revance Therapeutics, Inc.

Revance Therapeutics, Inc. Tech Stack

Revance Therapeutics, Inc. uses 8 technology products and services including Tableau, Salesforce, Font Awesome, and more. Explore Revance Therapeutics, Inc.'s tech stack below.

  • Tableau
    Business Intelligence
  • Salesforce
    Customer Relationship Management
  • Font Awesome
    Font Scripts
  • Modernizr
    Javascript Libraries
  • Web Vitals
    Javascript Libraries
  • Elementor
    Page Builders
  • iOS
    Programming Languages
  • Adobe Acrobat DC
    Rich Text Editors

Media & News

Revance Therapeutics, Inc.'s Email Address Formats

Revance Therapeutics, Inc. uses at least 1 format(s):
Revance Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@revance.comJohn.Doe@revance.com
55%
FLast@revance.comJDoe@revance.com
38%
FirstLast@revance.comJohnDoe@revance.com
5%
Last@revance.comDoe@revance.com
2%

Frequently Asked Questions

Where is Revance Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc.'s main headquarters is located at 1222 Demonbreun St, 20th Floor Nashville, Tennessee 37203, US. The company has employees across 5 continents, including North AmericaEuropeAfrica.

What is Revance Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Revance Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Revance Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc. is a publicly traded company; the company's stock symbol is RVNC.

What is Revance Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc.'s official website is revance.com and has social profiles on LinkedInCrunchbase.

What is Revance Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Revance Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, Revance Therapeutics, Inc. has approximately 674 employees across 5 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: N. M.Cfo & Executive Vice President Corporate Development: L. S.Chief Global Sales Officer & Evp Revance Aesthetics: M. M.. Explore Revance Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Revance Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Revance Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc.'s tech stack includes TableauSalesforceFont AwesomeModernizrWeb VitalsElementoriOSAdobe Acrobat DC.

What is Revance Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Revance Therapeutics, Inc.'s email format typically follows the pattern of First.Last@revance.com. Find more Revance Therapeutics, Inc. email formats with LeadIQ.

How much funding has Revance Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2025, Revance Therapeutics, Inc. has raised $100M in funding. The last funding round occurred on Mar 04, 2024 for $100M.

Revance Therapeutics, Inc.

Biotechnology ResearchUnited States501-1000 Employees

We are pleased to announce that Crown Laboratories and Revance Therapeutics are now united as REVANCE.

Section iconCompany Overview

Headquarters
1222 Demonbreun St, 20th Floor Nashville, Tennessee 37203, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
RVNC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
501-1000

Section iconFunding & Financials

  • $100M

    Revance Therapeutics, Inc. has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.

  • $250M$500M

    Revance Therapeutics, Inc.'s revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $100M

    Revance Therapeutics, Inc. has raised a total of $100M of funding over 17 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $100M.

  • $250M$500M

    Revance Therapeutics, Inc.'s revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.